The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes
Abstract
Resveratrol (3,5,4′‐trihydroxystilbene) is a natural compound found in several plants, including grapes, peanuts, and pines, and in their related products. Red wine is probably the most frequently consumed drink that is enriched in resveratrol. We investigated whether drinking resveratrol could suppress angiogenesis, a process of blood vessel growth involved in initiation, development, and progression of many diseases, including cancer, metastasis, and diabetic retinopathy. We found that resveratrol suppresses the growth of new blood vessels in animals. It directly inhibits capillary endothelial cell growth. It blocks both VEGF‐ and FGF‐receptor‐mediated angiogenic responses. In addition, resveratrol inhibits the phosphorylation of mitogen‐activated kinase isoforms (MAPK p44 /MAPK p42 ) induced by fibroblast growth factor‐2 in proliferating endothelial cells in a dose‐dependent manner. Oral administration of resveratrol significantly inhibits the growth of a murine fibrosarcoma in mice, and it significantly delays angiogenesis‐dependent wound healing in mice. Our findings suggest that ingestion of resveratrol‐enriched food could be beneficial for the prevention of cancer. However, its antiangiogenic effect could delay wound healing and possibly other angiogenesis‐dependent processes under physiological conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935 · cited 4×
“Its antitumor activity was observed in several tumor models and appears to be independent of cell type (2, 8).”
BackgroundMethodResultInfluentialEndostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Holmgren, L., O'Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,878
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., & Folkman, J. (1990) · Nature · doi:10.1038/348555a0 · Cited by 1,299
Pace-Asciak, C. R., Hahn, S., Diamandis, E. P., Soleas, G., & Goldberg, D. M. (1995) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06045-1 · Cited by 874
Angiogenesis inhibited by drinking tea
Cao, Y., & Cao, R. (1999) · Nature · doi:10.1038/18793 · Cited by 688
Self-citationCombined effects of angiostatin and ionizing radiation in antitumour therapy
Mauceri, H. J., Hanna, N. N., Beckett, M. A., Gorski, D. H., Staba, M.-J., Stellato, K. A., Bigelow, K., Heimann, R., Gately, S., Dhanabal, M., et al. (1998) · Nature · doi:10.1038/28412 · Cited by 668
Vascular endothelial growth factor C induces angiogenesis in vivo
Cao, Y., Linden, P., Farnebo, J., Cao, R., Eriksson, A., Kumar, V., Qi, J.-H., Claesson-Welsh, L., & Alitalo, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14389 · Cited by 565
Self-citationCardioprotective effect of resveratrol, a natural antioxidant derived from grapes
Hung, L. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00102-4 · Cited by 541
Quantitative angiogenesis assays: Progress and problems
Jain, R. K., Schlenger, K., Hockel, M., & Yuan, F. (1997) · Nature Medicine · doi:10.1038/nm1197-1203 · Cited by 385
Angiogenesis inhibition: A review
Auerbach, W., & Auerbach, R. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90027-2 · Cited by 321
Hsieh, T. C., Juan, G., Darżynkiewicz, Z., & WU, J. M. (1999) · PubMed · Cited by 293
Cao, R., Wu, H.-L., Veitonmäki, N., Linden, P., Farnebo, J., Shi, G.-Y., & Cao, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5728 · Cited by 185
Self-citationTumor invasion: molecular shears blunted by green tea
Garbisa, S., Biggin, S., Cavallarin, N., Sartor, L., Benelli, R., & Albini, A. (1999) · Nature Medicine · doi:10.1038/15145 · Cited by 174
VPF/VEGF and the angiogenic response
Dvorak, H. F. (2000) · Seminars in Perinatology · doi:10.1016/s0146-0005(00)80061-0 · Cited by 149
Caderni, G., Filippo, C. D., Luceri, C., Salvadori, M., Giannini, A., Biggeri, A., Remy, S., Cheynier, V., & Dolara, P. (2000) · Carcinogenesis · doi:10.1093/carcin/21.11.1965 · Cited by 147
Turner, R. T., Evans, G. L., Zhang, M., Maran, A., & Sibonga, J. D. (1999) · Endocrinology · doi:10.1210/endo.140.1.6460 · Cited by 105
Bertelli, A. A. E., Giovannini, L., Stradi, R., Urien, S., Tillement, J. P., & Bertelli, A. (1998) · PubMed · Cited by 93
Is Resveratrol an Estrogen Agonist in Growing Rats?
Turner, R. T. (1999) · Endocrinology · doi:10.1210/en.140.1.50 · Cited by 54
Therapeutic potentials of angiostatin in the treatment of cancer.
Cao, Y. (1999) · PubMed · Cited by 51
Self-citationLaMontagne, K. R., Moses, M. A., Wiederschain, D., Mahajan, S., Holden, J. T., Ghazizadeh, H., Frank, D. A., & Arbiser, J. L. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64832-8 · Cited by 50
Stability of resveratrol over time and in the various stages of grape transformation.
Bertelli, A. A. E., Gozzini, A., Stradi, R., Stella, S., & Bertelli, A. A. A. (1998) · PubMed · Cited by 21
Cited by
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Molecular targets of dietary agents for prevention and therapy of cancer
Aggarwal, B. B., & Shishodia, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.009 · Cited by 1,754
Gupta, S. C., Kim, J. H., Prasad, S., & Aggarwal, B. B. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9235-2 · Cited by 806
The Role of Resveratrol in Cancer Therapy
Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., Bishayee, A., & Ahn, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122589 · Cited by 800
Bråkenhielm, E., Veitonmäki, N., Cao, R., Kihara, S., Matsuzawa, Y., Zhivotovsky, B., Funahashi, T., & Cao, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308671100 · Cited by 732
Self-citation
Metadata
- Authors
- Brâkenhielm, E., Cao, R., & Cao, Y.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-06-08
- Volume
- 15
- Issue
- 10
- Pages
- 1798-1800
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2102950926
- Cited by
- 334
- References
- 25
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.